China / Yangtze River Pharmaceutical Group (YRPG) in Profile
One of the largest domestic pharma companies in China (ranking number one from 2014 to 2019), Yangtze River…
China
China / Boehringer Ingelheim's Stroke Rehab Centre Success & Continuing China Push
In March 2018, German pharma player Boehringer Ingelheim (BI)'s Consanas Rehabilitation and the Shanghai International Medical Center (SIMC) jointly established a Rehabilitation Medicine Center for stroke patients with the mission…
China / HiFiBiO CEO on the Keys to Global Biotech Success
HiFiBiO Therapeutics cofounder, CEO and CSO Dr Liang Schweizer fits the profile of a Chinese biotech CEO to a T:…
China / AstraZeneca/Junshi anti-PD-1 Tie-Up; New UK Biologics Plan for Pharmaron; Clover’s $230 Million Investment Boost
The latest from Chinese pharma, including a new deal between AstraZeneca and Junshi Biosciences; Innoforce and…
In Conversation
Yi (York) Chen – VP, Operations & Commercial Planning, Arctic Vision, China
Dr Yi (York) Chen, VP for operations and commercial planning at Arctic Vision shares his priorities, his wide experience of ophthalmology product launches in China, and how the company is positioning itself in relation to much larger companies in the Chinese ophthalmology market. Fundamentally, we are convinced that the China ophthalmology market is still a relatively blank slate with…
China / Top 10 Pharma Companies 2020
The Top 10 Chinese pharma companies for 2020 ranked by overall revenues. Taken from Fortune magazine’s 2020…
Related Report
Legal & Regulatory / China: Amended Drug Registration Regulation Aims to Strengthen and Streamline Regulation of New Drugs
On March 30, 2020, the State Administration for Market Regulation (SAMR) enacted the Amended Drug Registration…
NEW China Pharma Report out now!
Click here to register and download PharmaBoardroom’s latest report: Healthcare & Life Sciences Review:…
China’s Greater Bay Area and Hong Kong Life Sciences
One of the more eye-catching and ambitious initiatives to come out of last March’s National People’s Congress,…
China Set to Become OxyContin’s Second Largest Market
China is set to become the second largest market for Mundipharma’s OxyContin behind the US. It comes as…
Orphan Drug Accessibility & Social Medical Coverage in China
Kevin Rufang Huang is the president and founder of the Chinese Organization for Rare Disorders (CORD). A rare…
Career / China's Pharma Talent Story
Given the undeniably challenging and dynamic China market, most industry stakeholders would agree that the…
Biotech Spotlight / Alphamab Oncology, China
Founded in 2009 by CEO Dr XU Ting, Alphamab started its journey as a protein engineering company with the ultimate…
News Roundup / China Pharma May 25th 2020
A roundup of the latest news in Chinese pharma, including a US IPO for Burning Rock Biotech, positive news on…
News Roundup / China Pharma June 1st 2020
A roundup of some of the top stories in China’s healthcare and life sciences industry, including challenges for…
CanSinoBIO / China's Leading COVID-19 Vaccine Developer Talks Timelines
Chinese biotech CanSinoBIO is racing against the clock to have a COVID-19 vaccine ready to begin production in…
Regulatory Reform in China / The New Drug Administration Law
On 26 August 2019, the Chinese legislature, the National People’s Congress (NPC), passed the new Drug…
News Roundup / China Pharma May 11th 2020
Top recent news from Chinese pharma, including listings on the Hong Kong Stock Exchange, Junshi’s…
News Roundup / Chinese Pharma May 4th 2020
A selection of recent big stories from Chinese pharma, including Novo Nordisk’s updated China strategy,…
The Ideal Pharma Country Manager: China (Egon Zehnder)
Lydia Guo, Grace Zhao and Mendy Zhang of executive search firm Egon Zehnder outline some of the latest trends…
China / Pharma Partnerships News Roundup September 2020
Recent news from the cross-border deals and partnerships being struck by Chinese pharmacos, including I-Mab’s USD…
China’s Vaccine Crisis
One of China’s biggest vaccine manufacturers was found to have falsified rabies vaccine records causing…
The Ideal Pharma Country Manager: China (Ardent Search)
The lowdown on what it takes to be a country manager of a multinational pharma company in some of the world’s…
China / Yangtze River Pharmaceutical Group (YRPG) in Profile
One of the largest domestic pharma companies in China (ranking number one from 2014 to 2019), Yangtze River…
Coronavirus / Poised to Undermine China’s Healthcare Miracle?
Eurasia Group’s Aditya Bhattacharji examines the unfolding coronavirus outbreak, the prospects for…
China / Hitgen Aims to Strengthen its “Innovation Foundation” with UK & US Partnerships
PharmaBoardroom had the pleasure of interviewing HitGen chairman & CEO Dr Jin LI in July regarding the…
First Ever Biosimilar Approval in China: Trouble for Roche?
China’s regulator approved a biosimilar version of Roche’s Rituxan this week, the first such drug ever to be…
China / National Reimbursement Drug List (NRDL) 2020: What Reward for Innovation?
Eric Bouteiller examines the most recent update to China’s National Reimbursement Drug List, the positive impact…
Biotech / 5 More Biotechs to Watch in China
Earlier this year, PharmaBoardroom highlighted five of the most innovative and important biotech companies making…
Venture Capital and China’s Life Sciences: New Territories
Cash has always ruled the start-up world and when it comes to the healthcare and life sciences sphere, the heavy…
IP in China: From Imitation to Innovation
The Greater Bay Area’s – and in particular, Shenzhen’s – prowess in life sciences manufacturing…
China / Boehringer Ingelheim's Stroke Rehab Centre Success & Continuing China Push
In March 2018, German pharma player Boehringer Ingelheim (BI)‘s Consanas Rehabilitation and the Shanghai…
Hot Topics / MNCs in China
PharmaBoardroom recently analysed the contents of 10 interviews conducted with country managers at multinational…
China / Fosun Pharma Gearing Up to Bring mRNA COVID-19 Vaccine to Chinese Market
The collaboration between BioNTech and Pfizer on a COVID-19 vaccine candidate based on mRNA technology continues…
Company Spotlight / HiNouNou: Gamifying Preventative Health in China
As patients and consumers grow more educated and proactive in managing their own health and wellbeing, new ventures…